AAP
ALIM

Ardsley Advisory Partners’s Alimera Sciences ALIM Stock Holding History

Ardsley Advisory Partners’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,333
Closed -$121K – 189
2015
Q4 		$121K Buy
3,333
+2,666
+400% +$116K 0.02% 137
2015
Q3 		$22K Hold
667
– – 0.01% 145
2015
Q2 		$46K Sell
667
-666
-50% -$45.9K 0.01% 162
2015
Q1 		$100K Hold
1,333
– – 0.01% 183
2014
Q4 		$111K Buy
+1,333
New +$108K 0.02% 175

Other funds holding ALIM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Scale Management Foster City, California $359M AUM
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ardsley Advisory Partners's ALIM Position: Q1 2016 in Review

Ardsley Advisory Partners sold out of Alimera Sciences (ALIM) in Q1 2016, closing a stake of 3,333 shares — an estimated $121K sold.

Ardsley Advisory Partners first reported a position in ALIM in Q4 2014 and held it in 5 quarters. The position peaked at $121K in Q4 2015. 54 funds tracked by Wall St. Rank hold ALIM as of Q1 2016.

  • Ardsley Advisory Partners reported no remaining Alimera Sciences position as of Q1 2016 after selling out during the quarter.
  • Ardsley Advisory Partners sold 3,333 Alimera Sciences shares in Q1 2016, an estimated $121K.
  • Ardsley Advisory Partners first reported a position in Alimera Sciences in Q4 2014 and held it in 5 quarters.
  • Ardsley Advisory Partners's Alimera Sciences position peaked at $121K in Q4 2015.
  • 54 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2016.

Based on Ardsley Advisory Partners's 13F filing for Q1 2016, filed 16 May 2016.